Skip to main content
 

New Advances in Cancer Immunotherapy

Friday, December 1, 2017

Immunotherapy is one of the most exciting areas of new discoveries and treatments for different kinds of cancer. Understanding how the immune system works is opening the doors to developing new treatments that are changing the way we think about and treat cancer. On this episode, guest host Linda House is joined by Dr. Gerald Messerschmidt to talk about immunotherapy and its new advancements in recent years. Elizabeth Franklin also joins the program to discuss barriers and access to quality care for patients with cancer.

Hype or Hope? CIMAvax A Cuban Lung Cancer Vaccine

Friday, October 6, 2017

In the latest installment of our special series “Innovation Happens,” we take a look at CIMAvax, a promising lung cancer vaccine developed in Cuba that is getting a lot of attention here in the United States. It is being studied in an FDA approved clinical trial at Roswell Park Cancer Institute-- the first Cuban therapy to be tested in the US. Our guest is Dr. Mary Reid, the Director of Cancer Screening and Survivorship at Roswell Park and a key member of the team that is collaborating with Cuban scientists on CIMAvax. Dr. Reid shares with us the history of the vaccine and how it could spur a new age of American-Cuban medical collaboration.

Treatment Decision-Making Part 2: Knowing Your Options

Friday, October 6, 2017

As you or a loved one face complicated decisions about treatment and care, a proven strategy that helps is to be as prepared as possible. Doing your research and having a written list of questions can help you feel more organized and confident when you are working together with your health care team to find the treatment plan that is right for you. On this episode, host Kim Thiboldeaux talks to Margaret Stauffer, LMFT, Chief Mission Officer of the Cancer Support Community of San Francisco about the topic of treatment decision making and CSC's free treatment decision counseling program Open To Options.

Frankly Speaking About Cancer: Join host Kim Thiboldeaux, President and CEO of the Cancer Support Community, for a weekly radio broadcast empowering listeners to live well with cancer. Every Tuesday, 4PM ET (1PM PT)

The Promise of Biosimilars

Wednesday, September 13, 2017

In 2010, the Biologics Price Competition and Innovation Act signed into law by President Barack Obama as part of the Affordable Care Act, aimed to promote the development of biological products and create competition, with the goals of increasing treatment options and reducing health care costs. On this episode, we are joined by Dr. Leah Christl who is the Associate Director for Therapeutic Biologics in the Office of New Drugs in the FDA's Center for Drug Evaluation and Research. Today, we are starting to see the fruits of that labor, there are several biosimilars on the market and more are under review for approval. In 2015, the U.S. Food and Drug Administration approved the first biosimilar product which happens to be a supportive treatment for cancer patients undergoing chemotherapy for acute myeloid leukemia.

Frankly Speaking About Cancer: Join host Kim Thiboldeaux, President and CEO of the Cancer Support Community, for a weekly radio broadcast empowering listeners to live well with cancer. Every Tuesday, 4PM ET (1PM PT)

Treatment Decision-Making Part 2: Knowing Your Options

Wednesday, September 6, 2017

As you or a loved one face complicated decisions about treatment and care, a proven strategy that helps is to be as prepared as possible. Doing your research and having a written list of questions can help you feel more organized and confident when you are working together with your health care team to find the treatment plan that is right for you. On this episode, host Kim Thiboldeaux talks to Margaret Stauffer, LMFT, Chief Mission Officer of the Cancer Support Community of San Francisco about the topic of treatment decision making and CSC's free treatment decision counseling program Open To Options.

Frankly Speaking About Cancer: Join host Kim Thiboldeaux, President and CEO of the Cancer Support Community, for a weekly radio broadcast empowering listeners to live well with cancer. Every Tuesday, 4PM ET (1PM PT)

Treatment Decision-Making Part 1: Discussing End-of-Life Care

Wednesday, May 17, 2017

For people facing a cancer diagnosis, the path to completing cancer treatment can be long and difficult. The goal—to eliminate the cancer and go back to “normal.” However, for patients with advanced or stage 4 cancer, this goal may no longer be feasible. Patients face many tough decisions throughout the course of treatment, but one of the toughest decisions is deciding when it’s time to stop treatment. In part one of this two part series on patient decision-making, host Kim Thiboldeaux and return guest Charli Prather are discussing making decisions about end-of-life care and the importance of patient-provider communication.

Frankly Speaking About Cancer: Join host Kim Thiboldeaux, President and CEO of the Cancer Support Community, for a weekly radio broadcast empowering listeners to live well with cancer. Every Tuesday, 4PM ET (1PM PT)

Encore: Lifting the Fog of Chemo Brain

Tuesday, June 14, 2016

In spite of the fact that up to 60% of patients undergoing treatment for cancer develop chemo brain to some degree, many patients and their loved ones are caught off guard when they experience difficulty concentrating, finding the right words, short term memory loss, and multitasking. Chemo brain can have a significant impact on quality of life. Joining host Kim Thiboldeaux to explain this phenomenon, how it can impact your life, how the brain works and what treatments can help are guests Sue Harden, cancer survivor and Dr. Fremonta Meyer, staff psychiatrist at Dana-Farber Cancer Institute.

Frankly Speaking About Cancer: Join host Kim Thiboldeaux, President and CEO of the Cancer Support Community, for a weekly radio broadcast empowering listeners to live well with cancer. Every Tuesday, 4PM ET (1PM PT)

Encore: Lifting the Fog of Chemo Brain

Tuesday, March 15, 2016

In spite of the fact that up to 60% of patients undergoing treatment for cancer develop chemo brain to some degree, many patients and their loved ones are caught off guard when they experience difficulty concentrating, finding the right words, short term memory loss, and multitasking. Chemo brain can have a significant impact on quality of life. Joining host Kim Thiboldeaux to explain this phenomenon, how it can impact your life, how the brain works and what treatments can help are guests Sue Harden, cancer survivor and Dr. Fremonta Meyer, staff psychiatrist at Dana-Farber Cancer Institute.

Frankly Speaking About Cancer: Join host Kim Thiboldeaux, President and CEO of the Cancer Support Community, for a weekly radio broadcast empowering listeners to live well with cancer. Every Tuesday, 4PM ET (1PM PT)

Lifting the Fog of Chemo Brain

Tuesday, June 16, 2015

In spite of the fact that up to 60% of patients undergoing treatment for cancer develop chemo brain to some degree, many patients and their loved ones are caught off guard when they experience difficulty concentrating, finding the right words, short term memory loss, and multitasking. Chemo brain can have a significant impact on quality of life.

Joining host Kim Thiboldeaux to explain this phenomenon, how it can impact your life, how the brain works and what treatments can help are guests Sue Harden, cancer survivor and Dr. Fremonta Meyer, staff psychiatrist at Dana-Farber Cancer Institute.

Frankly Speaking About Cancer: Join host Kim Thiboldeaux, President and CEO of the Cancer Support Community, for a weekly radio broadcast empowering listeners to live well with cancer. Every Tuesday, 4PM ET (1PM PT)

Encore Presentation: Your Immune System and Cancer Treatment

Tuesday, June 2, 2015

Immunotherapy is one of the most exciting emerging areas of cancer treatment. Many experts now believe that it is well on its way to becoming a pillar of cancer treatment, along with surgery, radiation therapy and chemotherapy. The interest in immunotherapy isn't new. Researchers have been studying this for a long time, up until recently with disappointing results.

Joining host Kim Thiboldeaux to discuss this exciting treatment option is Dr. Kim Lyerly, Heather DiFilippo and Patty Spears.

Frankly Speaking About Cancer: Join host Kim Thiboldeaux, President and CEO of the Cancer Support Community, for a weekly radio broadcast empowering listeners to live well with cancer. Every Tuesday, 4PM ET (1PM PT)

Pages